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Abstract
Recent studies of the hippocampus have suggested that a network of genes is associated with the regulation of the GAD67
(GAD1) expression and may play a role in c-amino butyric acid (GABA) dysfunction in schizophrenia (SZ) and bipolar
disorder (BD). To obtain a more detailed understanding of how GAD67 regulation may result in GABAergic dysfunction, we
have developed an in vitro model in which GABA cells are differentiated from the hippocampal precursor cell line, HiB5.
Growth factors, such as PDGF, and BDNF, regulate the GABA phenotype by inducing the expression of GAD67 and
stimulating the growth of cellular processes, many with growth cones that form appositions with the cell bodies and
processes of other GAD67-positive cells. These changes are associated with increased expression of acetylated tubulin,
microtubule-associated protein 2 (MAP2) and the post-synaptic density protein 95 (PSD95). The addition of BDNF, together
with PDGF, increases the levels of mRNA and protein for GAD67, as well as the high affinity GABA uptake protein, GAT1.
These changes are associated with increased concentrations of GABA in the cytoplasm of ‘‘differentiated’’ HiB5 neurons. In
the presence of Ca
2+ and K
+, newly synthesized GABA is released extracellularly. When the HiB5 cells appear to be fully
differentiated, they also express GAD65, parvalbumin and calbindin, and GluR subtypes as well as HDAC1, DAXX, PAX5,
Runx2, associated with GAD67 regulation. Overall, these results suggest that the HiB5 cells can differentiate into functionally
mature GABA neurons in the presence of gene products that are associated with GAD67 regulation in the adult
hippocampus.
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Introduction
Decreased expression of the 67 kDalton isoform of glutamic acid
decarboxylase (GAD67) in the hippocampus has been reported in
numerous studies on schizophrenia and bipolar disorder [1,2,3,4],
two disorders that are thought to be neurodevelopmental in nature.
A complex network of genes plays a role in the regulation of GAD67
and shows uniquely different expression patterns in the two
disorders [3,5,6]. To understand how the differentiation of
GABAergic cells may contribute to dysfunction in neurodevelop-
mental disorders, it is imperative that novel methods are developed
for studying how the GABA cell phenotype is generated and
maintained during the pre- and postnatal periods in distinct brain
regions. GABA cells in the hippocampus develop in response to a
finely tuned temporal and spatial pattern of signals emanating from
the surrounding cells/tissues at different stages of phenotypic
differentiation [7]. These clues are fundamentally different between
cells developing in different regions, such as the hippocampus or
striatum, and the same stimulus can provoke different phenotypic
outcomes in GABA cells of different regions, depending upon the
collective effectof stimuli acting on them at a given point in their life
cycle [8,9,10]. Thus, in using a cell culture model to study GABA
neurons, it is imperative that these cells arephenotypically similar to
those endogenously present in the region under study. Toward this
end, we have established a novel in vitro model in which
multipotent progenitor cells in HiB5 hippocampal cultures are
differentiated into mature neurons that express GAD67 and other
genes associated with the GABA phenotype in the adult
hippocampus.
An important strength of the in vitro model described below is
that proliferating progenitor cells allow for the production of large
numbers of cells that can be driven towards a specific neuronal
phenotype, like that of GABAergic interneurons. Central nervous
system progenitor cells can give rise to both glia and neurons.
Conditionally immortalized progenitor cells have a consistent
lineage that allows them to differentiate into a cell line with a
specific phenotype. A number of GABAergic cell lines of striatal or
mesencephalic origin that express GAD67 and produce GABA in
vitro have been generated and used for molecular studies of GABA
cell regulation [11,12,13,14,15]. However, a GABAergic cell line
derived from the hippocampus has not as yet been developed and
will be of critical importance for in vitro modeling of GABA cell
differentiation and functional regulation, as it relates to this region.
Since the cellular environment, which influences the development
of a cellular phenotype, is different in distinct brain regions, it can
be safely be assumed that hippocampal GABA neurons are
different from those of striatal or mesenchymal origin. The HiB5
progenitor cell line has been derived from rat hippocampus taken
at embryonic day 16 (E16) [16] using the temperature-sensitive
tsA58 allele of the SV 40 large T antigen.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33352This HiB5 cell line has presented itself as a promising starting
point to produce hippocampal GABAergic neurons in vitro, so
that genes involved in the regulation of GAD67 can be studied
under highly controlled conditions. This model can be used to
characterize cellular and molecular changes associated with the
maturation of GABA cells and eventually develop cell-based
therapies [17,18] for disorders in which GABA cell dysfunction
plays a central role.
Materials and Methods
Cell culture, differentiation protocols and mRNA
evaluation
Neural precursor SV40 large T antigen-immortalized HiB5
cells originally prepared from Sprague Dawley rat embryonic
(E16) hippocampus [16] were kindly provided by Prof. Anders
Bjo ¨rklund, Lund, Sweden. The cultures were maintained in
proliferation medium consisting of Dulbecco’s Modified Eagles
Medium (Invitrogen) supplemented with 10% fetal calf serum
(FCS; Gibco-BRL) in 1% Penicillin-Streptomycin and a 5% CO2
environment at (33uC). To induce and maintain differentiation,
cells were incubated at 39uC in N2-supplemented serum-free
medium (DMEM/F12 1:1) plus additional neutirents. This change
in conditions was generally accompanied by a low amount of cell
death.
Various differentiation factors were tested for their potency to
induce GAD67 expression For basal culturing, an established
protocol for inducing differentiation of HiB5 cells towards a
neuronal phenotype was used [19]. After 2 days at 39uC, platelet
derived growth factor (PDGF; 30 ng/ml; Sigma) was added and
the cells incubated for another 2 days. To evaluate the influence of
treatment with growth factors on differentiating HiB5 precursor
cells, PDGF (30 ng/ml), 50 or 100 ng/ml BDNF, 50 ng/ml
NRG-1, or 10 ng/ml VEGF was added to the media containing
30 ng/ml PDGF for an additional 2 days. For the details of the
treatment scheme, refer to Figure 1. Total RNA was extracted and
subjected to quantitative RT-PCR. The growth factor concentra-
tions employed were based on those described in previous reports
[20,21,22,23,24,25,26,27]. None of the growth factors induced
higher GAD67 mRNA expression levels than the others.
Therefore, we decided to use the established protocol with PDGF
stimulation in further experiments. Since BDNF had been shown
before to induce morphological neuronal differentiation in HiB5
cultures and a neuronal phenotype was the second criterium for
GABAergic neuron phenotype, we stimulated the cells with BDNF
in addition to PDGF and analyzed GAT1 and GAD67 mRNA and
protein expression. Although the addition of BDNF did not
increase GAT1 or GAD67 further than PDGF alone, all further
experiments were conducted in the presence of PDGF and BDNF
(50 ng/ml) to ensure differentiation towards neuronal morphology.
Phenotype characterization
Cells were analyzed for expression of GAD67, and GAT1
mRNA using the TaqMan qPCR gene expression assay system.
Briefly, total RNA was isolated from HiB5 cells using the Trizol
reagent (Life Technologies). RNA was purified using RNeasy kit
reagents (Qiagen) and subjected to RNase-free DNase digestion.
The concentration and quality of total RNA was determined
spectrophotometrically. cDNA was generated from 1–2 mg RNA
per sample using the Superscript III Vilo cDNA synthesis kit
(Invitrogen) or High capacity cDNA reverse transcription kit
(Applied Biosytems). The expression levels of mRNA for various
genes were measured by real-time PCR using TaqMan Gene
Expression assays on Chromo4 Continuous Fluorescence Detec-
tion System (BioRad). For each sample and gene, three replicates
were run in a 96-well plate. The probes contain a 6-carboxy-
Figure 1. Treatment scheme for chronic influence of growth factors on expression of GABA cell marker. Cells were maintained for two
days under proliferation conditions (undifferentiated (undiff) as shown in the left picture). For the first 4 days of differentiation, a routine
differentiation protocol for HiB5 was followed (see methods section): after two days at 39uC in N2 medium, PDGF (30 ng/ml) was added and the cells
incubated for another 2 days. To study the influence of growth factors they were added at day 4 and cells incubated for another 2 days.
doi:10.1371/journal.pone.0033352.g001
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gene and a minor groove binder and nonfluorescent quencher at
the 39 end and are designed to hybridize across exon junctions. b-
2-microglobulin (VIC dye) was used as an endogenous control.
Real-time PCR reactions were carried out using 1–2 ml of cDNA
for each reaction in a 20 ml volume following the manufacturer’s
protocol. Gene expression values were determined as DCt (Ct2Ct
18s) and fold changes between different samples were determined
as DDCt (DCt vehicle2DCt).
Immunocytochemistry
The differentiated cells were fixed with ice-cold 4% parafor-
maldehyde in 0.1 M phosphate buffer (pH 7.4) for 20–30 minutes
and a standard immunofluroescence technique was used to
visualize various neuronal and molecular markers. Antibodies
used included monoclonal: anti-b-III-tubulin 1:1000 (Sigma); anti-
GAD67 1:1000 (Sigma); anti-PSD95 1:400 (Sigma); anti-Pax5 1:40
(BD Pharmingen); anti-Runx2 1:200 (R&D Systems); antiGAD65
1:50 (Sigma); anti-parvalbumin 1:100 (Sigma); and polyclonal:
rabbit anti-GABA 1:2000 (Sigma); rabbit anti-GAT1 1:100
(Phosphosolutions); rabbit anti-HDAC1 1:200 (Upstate Biotech-
nology); rabbit anti-DAXX 1:200 (Santa Cruz); rabbit anti-MAP2
1:500 (Millipore); anti-calbindin 1:50 (Millipore); rabbit antiGluR5
1:50 (Millipore); rabbit antiGluR6/7 1:50 (Millipore). Fluores-
cence (Alexa)-coupled secondary antibodies were raised in donkey
(Invitrogen) and used at 1:600. A Leica fluorescent or Leica TCS/
SP2 confocal microscope was used to evaluate fluorescent staining
using appropriate excitation beams and emission filters. For
confocal studies, all analyses were performed using the sequential
scanning mode to avoid channel bleeding and the detection of
spurious double labeling.
Cell Counting
All cell counts were performed on codified samples under
strictly blind conditions. In cell culture, 100 DAPI-positive nuclei
were expressed as the total number of cells in each condition.
Total cell number and the percent total counts for GABA-,
acetylated-tubulin- or nestin-positive neurons were determined
using cells grown on individual coverslips representing each
marker and were expressed as the number of cells per marker for
undifferentiated versus differentiated cells. The cell numbers were
expressed as means 6 standard deviations (SDs) for 5 independent
experiments. The statistical differences between the groups were
determined using a one- way ANOVA.
Western Blot
Cultured cells were washed with ice-cold PBS and harvested in
lysis buffer (T-Per tissue protein extraction reagent, Pierce)
containing 10 ml/ml protease inhibitor cocktail and 10 ml/ml
phosphatase inhibitor cocktail I and II each (Sigma-Aldrich).
Protein extracts were stored at 80uC. Fifty micrograms of protein
extracts from undifferentiated or differentiated HiB5 were
separated on 10% SDS-polyacrylamide gels and transferred onto
a PVDF membrane (BioRad). Protein expression of markers for
the GABAergic phenotype and other proteins of interest were
assessed using specific antibodies and standard Western blot
procedures. The antibodies employed were specific for GAD67
(1:1000; Sigma), GAT1 (1:100; Phosphosolutions), or b-actin
(1:5000) overnight at 4uC. Bands were visualized using chemilu-
minescence (ECL Western Blotting Analysis System and ECL
Hyperfilm, Amersham Biosciences). For statistical evaluation, blots
were scanned and analyzed using the public domain NIH image
program. Data were normalized using the respective loading
controls.
High-Performance Liquid Chromatography Analysis of In
Vitro GABA Synthesis
To examine the GABA release by HiB5 cells, cultured cells were
differentiated in (100620 mm
2) dishes as described above. GABA
release (into the medium) was examined by high-performance
liquid chromatography (HPLC) and detection with a Coulochem
III electrochemical detector to determine the basal or stimulated
level of GABA release into the medium.
After three rinses with artificial cerebrospinal fluid (aCSF)
(containing in mM: NaCl, 124; KCl, 3.0: KH2PO4, 1.25; CaCl2,
2.0; MgSO4, 1.0; NaHCO3, 26; glucose, 10; pH 7.4), the cells
were incubated with aCSF for 3 min. Supernatants were collected
and referred to as basal (time 0). Next, cells were depolarized for
15 minutes with 100 mM KCl (dissolved in aCSF) at 37uC. The
supernatants were collected and the concentration of GABA in the
medium determined by HPLC. Measurement of GABA was
performed by ESA Biosciences Inc. (Chelmsfords, MA, USA).
Briefly, derivatization with o-phthalaldehyde and 2- mercap-
taethanol was followed by reverse-phase isocratic liquid chroma-
tography with electrochemical detection.
Results
Evaluation of the influence of various growth factors on
GAD67 expression in HiB5 cells
Cell fate is determined by growth factor types, concentrations
and respective timing of treatment. To evaluate which growth
factors drive HiB5 cell differentiation towards a GABA phenotype
when applied acutely, cells were kept under differentiation
conditions (39uC, N2 medium) for 2 days, incubated for 2 more
days in the presence of PDGF to drive differentiation towards a
neuronal fate and then stimulated with different growth factors
(BDNF, NRG-1 or VEGF) two more days in the presence of
PDGF (treatment scheme Figure 1). Expression of the GABA
synthesizing enzyme GAD67 was measured using quantitative RT-
PCR. Differentiation conditions alone without acute growth factor
addition induced GAD67 mRNA expression significantly. Neither
NRG-1 nor VEGF or additional PDGF further increased the
expression of GAD67 mRNA above the level of cells cultured in
differentiation medium alone (Figure 2). Results for BDNF are
shown below.
Figure 2. Screening of growth factors for GAD67 increasing
activity in differentiated HiB5 cells. Cultured HiB5 cells were
switched to differentiation conditions. In the presence of PDGF, the
cultured cells were treated with NRG-1 or VEGF and cells were
incubated for 2 additional days. Controls were cultured in N2 medium
with PDGF alone. Cells were harvested in Trizol, the total RNA extracted
and subjected to quantitative RT-PCR. Data are expressed as fold
change of N2 control. (*#0.001 vs undiff).
doi:10.1371/journal.pone.0033352.g002
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Differentiated HiB5 cells
To ensure that the differentiated HiB5 cells expressed a
neuronal phenotype, mature neuron markers acetylated tubulin,
MAP2 and post-synaptic density protein 95 (PSD-95) were
employed in an immunofluorescence (IF) analysis of differentiated
vs. undifferentiated neurons. Additionally, the stem cell marker
nestin was used as control. Differentiated HiB5 cells showed
increased amounts of acetylated tubulin, MAP2 and PSD-95
compared with undifferentiated cells (Figure 3 A–C), showing that
differentiation conditions resulted in mature neurons. Undifferen-
tiated cells, in contrast, showed high levels of nestin expression,
which was virtually undetectable in differentiated cells (Figure 3D).
Quantitative evaluation of acetylated tubulin- and nestin-positive
cells showed almost 100% differentiation (Table 1).
Expression of GABA Neuron-Specific Markers in
Differentiated HiB5 Cells
To evaluate whether functional differentiation of neurons was
occurring in the HiB5 cultures, HiB5 cells were treated with N2
alone, PDGF alone and combinations of PDGF and 50 or 100 ng/
ml BDNF, respectively. Two specific functional markers for GABA
neurons, GAD67 and GAT1, were evaluated in differentiated vs
undifferentiated cells, using quantitative RT-PCR. Differentiated
HiB5 cells expressed significantly more GAD67 (Figure 4A) and
GAT1 (Figure 4B) mRNA. However, there was no difference
between the treatment groups within the differentiated HiB5.
Whena combination of PDGFand 50 ng/mlBDNF were usedin
subsequent experiments, Westernblot analysis of GAD67 and GAT1
in differentiated vs undifferentiated HiB5 cells showed a significant
increase in both GAD67 and GAT1 protein (Figure 4C, D).
To evaluate whether undifferentiated cells also show increases of
GAD67, IF with GAD67 -specific antibodies was co-localized with
DAPI for visualization of cell nuclei. As shown in Figure 4E,
differentiated cells with numerous neurites expressed high levels of
GAD67. In contrast, undifferentiated cells showing no neuritic
processesexpressedlittle orno GAD67, (Figure 4G). Asevaluated by
confocal microscopy, differentiated HiB5 cells showed immunoflu-
orescence for both GAD67 and GAT1 (Figure 4F).
Synthesis of GABA and Stimulus-Dependent Release
from Differentiated HiB5 Cells
Differentiated HiB5 cells showed high levels of GABA-
immunofluorescence that was virtually absent in undifferentiated
cells (Figure 5A). This seems to be in contrast with GAD67
expression which was detected in undifferentiated HiB5 with
Western blot analysis: however, this technique is only semi
quantitative and trace amounts of GAD67 might not be enough to
produce enough GABA to be detectable with antibody staining.
Both the cell soma and neuritic processes of differentiated HiB5
contained a strong GABA-IF signal. As the fibers extended with
time, the intensity of GABA-IF was very intense in cell bodies.
Using KCl, stimulus-dependent release of GABA from differen-
tiated cells into the medium was evaluated, using high sensitivity
chromatographic analyses of the aCSF medium. Upon stimulation
with KCl (Figure 5B), differentiated HiB5 cells released a
significant amount of GABA compared with basal, matching the
GABA-immunofluorescence staining patterns described above.
Further characterization of the GABA phenotype
Hippocampal GABA neurons express GAD65, and calcium
binding proteins such as calbindin and parvalbumin (PARV). To
characterize differentiated HiB5 cells further, we used immuno-
fluorescence to assess expression of GAD65, parvalbumin and
calbindin in theses cells. All three proteins were upregulated in
differentiated HiB5 (Fig. 6A–C).
Figure 3. Expression pattern of mature neuron markers acetylat-
ed tubulin, MAP2 and PSD-95 and stem cell marker nestin in
undifferentiated and differentiated HiB5 cells.Specific markers were
detected using primary antibodies and immunofluorescence detection
with DAPI as nuclear counter stain. Detectable levels of IF were associated
with, acetylated tubulin (A); MAP2 (B); PSD-95 in differentiated HiB5 cells
(C), while nestin (D) is only seen in undifferentiated cells.
doi:10.1371/journal.pone.0033352.g003
Table 1. Quantification of cells expressing differentiation
stage-specific markers.
Marker Undifferentiated Differentiated
GABA 1619 2 63*
Acetylated tubulin 2619 4 64*
Nestin 97631 61*
The data represent 100 cells/coverslips that were analyzed using cells
grown on 5 different coverslips per marker and differentiation state.
Statistical significance was calculated by one-way ANOVA, followed
by Tukey test.
*: p,0.001 for GABA undiff. vs GABA diff., tubulin undiff. vs. tubulin
diff., nestin undiff. vs. nestin diff., respectively Data are expressed as
means ± SD.
doi:10.1371/journal.pone.0033352.t001
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Network
IF was used to co-localize GABA with HDAC1 and DAXX,
two genes associated with epigenetic suppression of GAD67
promoter activity. In differentiated HiB5 cells (Figure 7 A–B),
both factors were expressed in GABA-positive HiB5 cells.
HDAC1-IF was localized in the nucleus of these cells, while
DAXX-IF was found in the nucleus and cytoplasm. Two
transcription factors, PAX5 and Runx2, also associated with a
GAD67 regulatory network [3] were co-localized with GABA–IF
in differentiated HiB5 cells (Figure 7C–D). Regulation of GAD67
in hippocampus in schizophrenia is also associated with the
regulation of glutamate receptors. Therefore we were interested to
see whether these receptors were expressed in our model system.
We could detect GluR5 in differentiated HiB5 (Figure 8A). Since
commercially available antibodies detected both GluR6 and
GluR7, (Figure 8B), we verified by qRT-PCR that both GluR6
and GluR7 were expressed in differentiated HiB5 (data not
shown).
Discussion
The results of this study have demonstrated that a phenotype
similar to that of hippocampal GABA neurons in vivo can be
induced in vitro using the HiB5 cell line. This conditionally
immortalized precursor cell line can serve as a basis for studying
the regulation of GAD67 expression in hippocampal GABAergic
neurons. GAD67 (GAD1) appears to be regulated by a complex
and diverse network of genes that includes growth factors,
elements of the TGFb and Wnt signaling pathways, transcription
factors and epigenetic regulation of promoters [3]. Growth factors
Figure 4. Induction of expression of key GABA cell markers GAD67 and GAT-1 in differentiated HiB5 cells. (A, B): Cells were
differentiated at 39uC in N2 for two days, followed by addition of PDGF (30 ng/ml) for an additional two days. This was followed by stimulation for
two days with growth factors. Quantitative (q) RT-PCR for GAD67 or GAT1 was used to measure changes in mRNA expression in the presence N2
supplement plus PDGF alone; additional PDGF (P); or a combination of additional PDGF and BDNF (B; 50 and 100 ng/ml respectively). Values are
expressed as fold increases in differentiated cells compared with undifferentiated controls (GAD67 vs undiff: *#0.05; GAT1: vs undiff ***#0.001). C,
D: Western blot with b-actin as loading control was used for quantification of proteins. (*#0.05 vs undiff). GAD67 and GAT-1 were detected using
specific antibodies. (E): DAPI (blue) was used as nuclear counter stain for GAD67 containing cells (green). (F): GAD67 (green) was co-localized with
GAT1 (red) in the same differentiated cells (yellow overlay color) (G) GAD67 (green) in undifferentiated HiB5 cells; DAPI (blue): cell nuclei.
doi:10.1371/journal.pone.0033352.g004
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differentiation of HiB5 towards a GABAergic neuronal phenotype.
A major advantage of using an in vitro culture system of this
type is the fact that a preponderance of differentiated neurons with
the GABA cell phenotype can be generated in relative isolation,
making it possible to experimentally manipulate them using a
variety of genetic, pharmacological and physiological strategies.
Differentiated cells are a prerequisite for biochemical character-
izations; however, it is difficult to obtain them in large numbers.
By using immortalized precursor cells that proliferate and generate
progeny, this problem can be routinely overcome [27]. Generally
speaking, the differentiation into a neuronal phenotype is a
combinatorial process in which intrinsic genetic programs are
activated by extracellular growth factors. By controlling the type,
amount and duration of exposure of specific growth factors to
which precursor cells are exposed, it is possible to direct them
towards a specific cell fate [28]. HiB5 are multipotent progenitor
cells with the potential for developing into either glia or neurons,
depending upon their extracellular environment [29,30,31]. As
demonstrated in this report, by addition of a specific panel of
growth factors that includes PDGF and, BDNF, undifferentiated
HiB5 precursor cells can be pushed toward a differentiated state
with a GABAergic phenotype.
The ability of HiB5 cells to develop into GABAergic neurons
may be related to their having been generated from embryonic
tissue. During the prenatal developmental stages E13 and E14 of a
21day gestational period in rats, undifferentiated neuroepithelial
cells express the intermediate filament nestin. By E16, a wave of in
vivo neurogenesis typically begins in the hippocampus and
continues into the early post-natal period when post-mitotic
neurons begin to appear in the ventricular and subventricular
areas. By E19, the ventricular zone stops producing neurons, while
the subventricular zone continues to generate both neurons and
glia [31,32,33,34]. HiB5 cells derived from E16 rats retain the
developmental potential of their nestin-positive precursors, even
when they are at the brink of differentiating into neurons. These
preconditions suggest that undifferentiated neuronal precursor
cells might respond optimally to extracellular cues that have the
potential to drive them towards a neuronal fate. Other immortal
hippocampal cell lines dissected from the rat hippocampus
between E17 and E18 are capable of generating both neuronal
and glial lineages [35]. Due to their origin from a later embryonic
stage, however, these cells might not have the unique combination
of stem cell properties and early neuronal predisposition of the
HiB5 cell at E16 that enables differentiation towards a GABAergic
phenotype. Multipotent stem cells can give rise to different
Figure 5. Synthesis of GABA and stimulation-induced release from differentiated HiB5 cells. (A) GABA was detected using a specific
antibody against GABA. (B) GABA release was detected in artificial cerebrospinal fluid (aCSF) without KCl (basal) or with 100 mM KCl (stimulation) in
the presence of Ca
2+. GABA concentrations in aCSF were determined using HPLC. The data represent the mean 6 SEM for GABA release from 6
independent culture experiments (***#0.0004 vs baseline levels in differentiated cells).
doi:10.1371/journal.pone.0033352.g005
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multipotent progenitor state into a mature differentiated neuron
can be mapped using stage-specific markers, such as nestin, a
marker for undifferentiated stem cells [39]. Once mature
neurofilament constituents and synaptic proteins appear in the
cells [40,41], neuronal processes begin to sprout. Typical markers
for neuronal maturation of HiB5 cells, including acetylated
tubulin, MAP2 and PSD-95, were present in ‘‘differentiated’’
HiB5 cells, supporting the conclusion that the latter had developed
a mature neuronal phenotype.
Differentiation is guided by extracellular stimuli [28], and
several growth factors, such as BDNF, VEGF, NRG-1 and PDGF
have been linked to the differentiation of GABAergic neurons.
BDNF is capable of inducing a GABAergic phenotype in
hippocampal granule cells in vivo [21,22,42] and increases the
expression of GAD67 in primary hippocampal cultures from the
dentate gyrus obtained from adult mice [23]. Following a
cerebrovascular accident (CVA), VEGF increases cortical neuron
number, the formation of new GAD67-positive dendrites and is
capable of inducing the maturation of differentiated GABA
neurons [43]. In the adult brain, neuregulin-1 (NRG-1) and its
receptors ErbB2,-3,-4 are expressed in neurogenic regions like the
subventricular zone and the hippocampal dentate gyrus [44,45].
Interestingly, the signaling of neuregulin 1 via its ErbB4 receptor is
altered in schizophrenic patients [46], and ErbB3 expression is
decreased in the frontal cortex of these patients [47,48]. A number
of earlier studies had indicated that PDGF promotes neuronal
differentiation in HiB5 cells [19,49,50,51,52,53].
Exposure to specific growth factors, such as VEGF NRG-1 and
BDNF, did not further increase GAD67 expression in HiB5 cells
when compared to PDGF alone. Even so, BDNF stimulates the
differentiation of progenitor cells in HiB5 cultures towards a
mature neuronal phenotype [19] and promotes early steps in the
morphological differentiation and maturation of hippocampal
neurons [54,55]. BDNF has also been associated with the
formation of inhibitory synapses and increases in the number
and length of axons of GABAergic neurons in E16 primary
cultures [42] In the current study, the inability of the growth
factors to further induce the GAD67 gene might be related either
to the fact that the cultured cells were stimulated for a relatively
Figure 6. Expression of GAD65, parvalbumin and calbindin in undifferentiated and differentiated HiB5 cells. Antibodies were used to
detect specific proteins (A) GAD65 (green) (B) parvalbumin (green, right) (C) expression of calbindin (red). Blue: cell nuclei counter stained with DAPI.
doi:10.1371/journal.pone.0033352.g006
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33352Figure 7. Co-localization of epigenetic regulators HDAC1 and DAXX, developmental transcription factors PAX5 and Runx2 with
GAD67 in differentiated HiB5 cells. Specific antibodies were used to detect several proteins expressed by the target genes associated with a
GAD67 regulatory network. GAD67 (green) was co-localized with (A) HDAC1 (red); (B) DAXX (red) and GABA (green) with (C) PAX5 and (D) Runx2 (red
fluorescence, respectively).
doi:10.1371/journal.pone.0033352.g007
Figure 8. Co-localization of GAD67 with (A) GluR5 and (B) expression glutamate receptor subunits GluR6/7 in differentiated cells.
Specific antibodies were used to detect glutamate receptor subunits. (A) GluR5 expression in differentiated HiB5 cells; (B) GluR6/7 expression in
differentiated HiB5 cells. GluRs (red) was co-localized with GAD67 (green).
doi:10.1371/journal.pone.0033352.g008
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the culture was already close to a maximum 4 days in
differentiation conditions (2days N2, 2days N2 plus PDGF). It is
not clear why other growth factors did not further stimulate the
differentiation of the GABA phenotype; however, as described
before, the combination of extrinsic and intrinsic factors associated
with a cell stimulation decides its fate, and a growth factor may
work well in one environment, but not another, because the
analogous environmental conditions are different. As discussed for
BDNF, GAD1 activation in differentiated HiB5 cells might have
attained a maximum level of expression, once the cells were
exposed to the appropriate differentiation conditions (i.e. N2 and
39uC and PDGF stimulation).
Terminal differentiation of GABAergic neurons requires the
activation and regulation of many different genes that are
necessary for the synthesis, vesicular packaging and release of
GABA. In the current study, expression of GAD67 and GAT1
marked the terminal differentiation of HiB5 neuronal precursor
cells and was associated with the synthesis and release of GABA
from these same cells. Further, differentiated HiB5 cells expressed
GAD65, parvalbumin and calbindin. GABAergic hippocampal
interneurons expressing calbindin are altered in schizophrenia
[56]. Parvalbumin-positive GABA neurons are involved in neural
synchrony and in the altered network oscillation in schizophrenia
[57]. Thus, our findings that differentiated HiB5 cells in our model
are calbindin – and parvalbumin –positive further validate our
model for the study of GABA cell regulation under pathophys-
iological conditions.
Differentiated HiB5 cells express glutamate receptor subunits
which have been found to be regulated in human hippocampus in
association with schizophrenia. Additionally, two epigenetic
factors (HDAC1 and DAXX) and two transcription factors
(PAX5 and Runx2), were also detected in the terminally
differentiated GABAergic cells. These genes are associated with
the regulation of GAD67 in GABAergic interneurons of the adult
human hippocampus [3] and their appearance in the differenti-
ated HiB5 cells coincides with the expression of GAD67 protein by
these cells. It is noteworthy that HDAC and DAXX show
increased expression in schizophrenia, while PAX5 and Runx2
show decreased transcripts in bipolar disorder, two disorders in
which parallel reductions in the expression of GAD67 have also
been reported in a layer of the hippocampus that exclusively
contains neurons of the GABAergic type [3]. The molecular
endophenotypes that are associated with a common cell phenotype
may be quite unique in different disorders in which GABA cell
dysfunction is present.
Conclusion
Taken together, the results of this study suggest that terminally
differentiated GABA cells in HiB5 hippocampal cultures may
provide a useful model for studying the molecular regulation of
GAD67 in post-mitotic GABA cells of the hippocampus, as they
may relate to various types of neurodevelopmental and neuropsy-
chiatric disorders.
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